crispr/cas9 plasmid, c32-447
Gene therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 15, 2018 (NCT03057912)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
CDK11B inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- crispr/cas9 plasmid, c32-447
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03057912 | Phase 1 | Jan 15, 2018 | Jingchu University of Technology, Sun Yat-Sen University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jingchu University of Technology | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 1 | 1 | 2018 |
2 organizations
Page 1 / 1